Description
As the need for access to guideline-concordant biomarker testing for underserved populations continues to grow, hear what care teams need to know about coverage for Medicaid beneficiaries and the legislative outlook for 2024. In this episode, CANCER BUZZ speaks with Hilary Gee Goeckner, MSW, director of State and Local Campaigns for the American Cancer Society Cancer Action Network (ASC CAN), who shares policy perspectives and the latest on state legislation to expand coverage for biomarker testing for Medicaid beneficiaries.
“There are a lot of challenges around implementation—getting the legislation passed is just the first step…It is also important for providers to be aware of the new rules that affect many plans and their states so they are able to order testing that may not have been covered or rejected previously.” –Hilary Gee Goeckner, MSW
Hilary Gee Goeckner, MSW
Director, State and Local Campaigns, Access to Care
American Cancer Society Cancer Action Network
Washington, D.C.
This episode was developed in connection with the ACCC education program Improving Access to Biomarker Testing in Medicaid Populations and is made possible with support by Foundation Medicine and Exact Sciences.
Resources:
The Cost of Biomarker Testing: Moving from Support-Based to Sustainable Solutions
Comprehensive Cancer Care: The Role of Biomarker Testing
Biomarker Testing for Medicaid Beneficiaries (Podcast)
Access to Biomarker Testing - American Cancer Society Cancer Action Network
The Road to Comprehensive Biomarker Testing for All – ACCC Buzz Blog
Improving Access to Biomarker Testing in Medicaid Populations
Precision Medicine in Rural and Underserved Areas – ACCC Buzz Blog
Patient Perceptions of Biomarker Testing – Oncology Issues
Cancer Diagnostics - Biomarkers
Eliminating Precision Medicine Disparities
The range of frontline therapy options for mantle cell lymphoma can influence subsequent treatment choices for patients with relapsed or refractory disease. Providers must determine initial treatment based on individual patient characteristics, while also factoring in future treatment options. In...
Published 09/19/24
Advancements in treatment combined with a multimodal approach are improving outcomes for patients with head and neck cancer. However, the unique challenges of a head and neck cancer diagnosis and its treatment side effects—such as speech and communication difficulties as well as negative effects...
Published 09/12/24